Inhalytic Ltd is an analytical chemistry testing consultancy set up by Frank Chambers (Formerly of AstraZeneca and Mylan) in July 2018. We specialize in proof of concept testing and early phase development for pharmaceutical delivery platforms, particularly in the analysis of Orally Inhaled and Nasal Drug Products (OINDP’s). We are a small team of Analytical Chemists with combined experience of over 50 years of working within global pharmaceutical industries. Working to high standards, we offer a fast turnaround of analytical testing within our laboratory at Discovery Park in the south-east of England, using techniques such as NGI and HPLC.